These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33861588)

  • 1. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
    Jin Z; Zhou L; Tian R; Lu N
    Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
    Shao B; Pennathur S; Heinecke JW
    J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
    Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW
    J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
    Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
    J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
    Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
    J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
    Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.
    Shao B
    Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
    Lu N; Xie S; Li J; Tian R; Peng YY
    Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.
    Zheng L; Settle M; Brubaker G; Schmitt D; Hazen SL; Smith JD; Kinter M
    J Biol Chem; 2005 Jan; 280(1):38-47. PubMed ID: 15498770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Chem Res Toxicol; 2010 Mar; 23(3):447-54. PubMed ID: 20043647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
    Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
    Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
    Nicholls SJ; Zheng L; Hazen SL
    Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.
    Vivekanandan-Giri A; Slocum JL; Byun J; Tang C; Sands RL; Gillespie BW; Heinecke JW; Saran R; Kaplan MJ; Pennathur S
    Ann Rheum Dis; 2013 Oct; 72(10):1725-31. PubMed ID: 23313808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
    Zamanian-Daryoush M; Gogonea V; DiDonato AJ; Buffa JA; Choucair I; Levison BS; Hughes RA; Ellington AD; Huang Y; Li XS; DiDonato JA; Hazen SL
    J Biol Chem; 2020 Apr; 295(15):4836-4848. PubMed ID: 32098873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway.
    Shao B; Heinecke JW
    J Proteomics; 2011 Oct; 74(11):2289-99. PubMed ID: 21501700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Curr Opin Cardiol; 2006 Jul; 21(4):322-8. PubMed ID: 16755201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using adenovirus-mediated gene transfer to study the effect of myeloperoxidase on plasma lipid levels, HDL structure and functionality in mice expressing human apoA-I forms.
    Dalakoura-Karagkouni K; Tiniakou I; Zannis VI; Kardassis D
    Biochem Biophys Res Commun; 2022 Sep; 622():108-114. PubMed ID: 35843089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export.
    Shao B; Tang C; Heinecke JW; Oram JF
    J Lipid Res; 2010 Jul; 51(7):1849-58. PubMed ID: 20064972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.